VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | The importance of proteomic analysis in myeloma and future outlooks

Arun Wiita, MD, PhD, University of California, San Francisco, CA, shares some insights into a session held at IMS 2022 which focused on the importance of proteomic analysis in multiple myeloma, and further discusses how proteomics can provide valuable information on mechanisms of myeloma progression and response to therapies. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter